Member Info for alkin

Hi Jim, PHE had £9m+ in the back at the end of last year, not sure they need a placement

Polygon will continue to hoover up shares remaining under 30% until 21 Feb 23. On this day they can buy SNG outright for 35p per share (the highest value in the last 12 months).
However, once there is a bit of positive move this may also force their hand

When you consider UK cost of bed in ICU is around £1.5k and USA varies from $1,500 - $4,500, then SNG is cheap if it prevents this alone

Problem all along with HUI / PHE is getting up and running. By engaging with a power company, they are use the hydrogen generated to produce power 24/7, which is great thinking by HUI.

Just can't afford to stay at this price by Feb 2023 otherwise we will get 35p per share...

Article is from 22 Sept, a week ago! Has covid gone now then, if so why are we dishing out boosters...
UK hospital admissions from covid up 47.7% in the last week, positive tests up 42.4%, your right it looks like Covid is gone...
https://coronavirus.data.gov.uk/

Where have you been, we were over £2

Hi Doc, any more info on Strive?

Tommy-D I remain invested in the hope we will realise some value.
The point I was trying to get at is that if Poly (now TFG) decided to buy at the end of February 2023 and hit 30%, they could then buy the company for 35p per share (the highest price for the last 12 months). I was trying to calculate what the losses would be worth to them in financial terms when offset against profits..
Just wondered if anyone had any ideas on this (my original question)?

LOL- we just don't seem to be very good at pushing...

Hi Fruitsnveg, I am surmising, not sure this is correct.

Just a quick one, if the share price remains low until end of feb 23, does that mean TFG (formally Polygon) can purchase the company at 35p per share (this being the highest price for last 12 months)?
Also, would they benefit from the £70m+ loss @ 19% + R&D tax claim making this worth somewhere in the region of 33.35% (£23m+)..

Have to say sceptical about seeing results for another few months. Not sure why but SNG seem lacking in pushing things forward.
We all know there was no reason not to proceed with Activ-3 trials other than SNG being a UK company of a size that could just be ignored.
With the money spent on various trials its obvious to anyone on this board that the management are not connected enough to make this good product a success.

Have I missed the ACTIV-2 Trial data update, remember the RNS saying first half of this year

A lot of negativity on this chat.
Lots of us got stung waiting for good P3 results but please don't think the directors are just at Synairgen for the salaries, they have share options for a reason...

I love the "big boys" banter - name the time & place, I thought we had moved past the school playground!

We all know PHE will sore once a plant is operational and producing hydrogen from plastic waste. Here's an idea, lets wait patiently like grown ups!

Agree, PHE should be pushing the case for plants around the UK. If China can build a hospital in a week, surely we can get PHE plants up and running in a few months.

Hi Seafllat, if LINDE were supposed to be doing a deal with HUI in Poland then surely the writing is on the wall if HUI are now doing a deal with PHE?

Not been online for couple of weeks, based on the RNS re. Poland, presume LINDE not going ahead with HUI/PHE then?

Jet engines good as well as they don't emit harmful nitro oxide